PharmaResearch Acquires TURINGBIO, a Digital Healthcare Solution Company
Securing the ability to
develop AI solutions ... to lead the way globally in aesthetic and medical
innovation
PharmaResearch (CEOs: Ki Seock Kang, ThinKyou
Kim), a biopharmaceutical company, announced that it has acquired TURINGBIO (CEO:
Michael Shim), an AI-based digital healthcare solution company.
This acquisition is expected to give
PharmaResearch access to highly qualified developers in the field of Digital
Therapeutics (DTx), as well as the ability to apply AI technology to the
aesthetics and medical business to further advance its expertise and
capabilities in the market.
As an AI-based digital healthcare solution
company founded in 2020, TURINGBIO has developed and supplied a range of
products, including DepRx®, an evidence-based digital treatment device for
depression, WeeDool®, a personalized comprehensive psychological counseling
platform using generative AI, and VitalTracker®, a digital phenotype data
tracking and prediction system for quantitative diagnosis of mental illness.
“We decided to make this acquisition as digital transformation is
increasingly required in the pharmaceutical and bio industries,” said ThinKyou Kim, CEO of PharmaResearch. “TURINGBIO’s excellent AI solution capabilities will help us
accelerate DTx-related research and development and lead innovative
technologies in aesthetics and medicine globally through synergies with our
existing businesses.”
“This collaboration is a significant leap forward for us,” said a TURINGBIO official, “Combining PharmaResearch’s regenerative medicine expertise and
infrastructure with TURINGBIO’s generative AI digital health technology will
help us develop more innovative and customized solutions.”
ParmarResearch is a regenerative medicine-based bio-pharma company that produces and sells pharmaceuticals, medical devices, cosmetics, and health supplements based on its tissue regeneration technologies DOT™PDRN and DOT™PN. The company offers a range of products, including REJURAN®, REJUVIEL®, CONJURAN®, REJURAN Cosmetics, and Re-An® Eye Drops, REJUDERMA®, and REJUVENEX® Cream.